tiprankstipranks
Biodexa Pharmaceuticals (BDRX)
NASDAQ:BDRX
US Market
BDRX
Biodexa Pharmaceuticals
RESEARCH TOOLSreports

Biodexa Pharmaceuticals (BDRX) Ratios

538 Followers

Biodexa Pharmaceuticals Ratios

BDRX's free cash flow for Q4 2025 was £0.00. For the 2025 fiscal year, BDRX's free cash flow was decreased by £ and operating cash flow was £0.00. See a summary of the company’s cash flow.
Ratios
TTM
Dec 25Dec 24Dec 23Dec 22
Liquidity Ratios
Current Ratio
 2.03 2.03 1.75 1.26 2.47
Quick Ratio
 2.03 2.03 1.75 1.39 2.47
Cash Ratio
 1.39 1.39 0.33 1.07 1.49
Solvency Ratio
 -0.92 -0.90 -0.87 -1.16 -3.17
Operating Cash Flow Ratio
 -0.92 -0.88 -2.44 -1.23 -3.71
Short-Term Operating Cash Flow Coverage
 -92.45 -88.59 0.00 0.00 0.00
Net Current Asset Value
£ 5.66M£ 5.66M£ 2.35M£ 1.17M£ 2.33M
Leverage Ratios
Debt-to-Assets Ratio
 <0.01 <0.01 0.05 0.04 0.11
Debt-to-Equity Ratio
 <0.01 <0.01 0.09 0.10 0.20
Debt-to-Capital Ratio
 <0.01 <0.01 0.08 0.09 0.16
Long-Term Debt-to-Capital Ratio
 0.00 0.00 0.00 0.00 0.00
Financial Leverage Ratio
 1.59 1.59 1.78 2.25 1.75
Debt Service Coverage Ratio
 -48.67 -61.70 0.00 -164.76 -140.17
Interest Coverage Ratio
 -72.31 -120.77 0.00 -195.46 -168.53
Debt to Market Cap
 0.12 0.13 0.00 0.00 0.00
Interest Debt Per Share
 0.80 2.36 11.73 1.63K 43.71K
Net Debt to EBITDA
 0.98 1.05 0.10 0.77 0.27
Profitability Margins
Gross Profit Margin
0.00%0.00%0.00%-967.45%-631.19%
EBIT Margin
0.00%0.00%0.00%-1953.81%-1206.72%
EBITDA Margin
0.00%0.00%0.00%-1879.53%-1181.83%
Operating Profit Margin
0.00%0.00%0.00%-2103.41%-1277.83%
Pretax Profit Margin
0.00%0.00%0.00%-1964.57%-1214.31%
Net Profit Margin
0.00%0.00%0.00%-1858.01%-1095.28%
Continuous Operations Profit Margin
0.00%0.00%0.00%-1858.01%-1095.28%
Net Income Per EBT
98.37%98.38%95.82%94.58%90.20%
EBT Per EBIT
74.06%76.76%65.00%93.40%95.03%
Return on Assets (ROA)
-35.09%-34.41%-38.76%-67.15%-138.57%
Return on Equity (ROE)
-55.81%-54.85%-68.84%-151.33%-242.13%
Return on Capital Employed (ROCE)
-72.66%-68.74%-94.39%-161.15%-246.40%
Return on Invested Capital (ROIC)
-72.30%-67.29%-85.12%-147.40%-212.80%
Return on Tangible Assets
-50.90%-49.90%-62.72%-93.13%-138.72%
Earnings Yield
-964.41%-1351.18%-57.15%-4337.92%-758.82%
Efficiency Ratios
Receivables Turnover
 0.00 0.00 0.00 0.54 2.12
Payables Turnover
 0.00 0.00 7.69 12.95 15.08
Inventory Turnover
 0.00 0.00 0.00 -5.78 0.00
Fixed Asset Turnover
 0.00 0.00 0.00 0.67 0.84
Asset Turnover
 0.00 0.00 0.00 0.04 0.13
Working Capital Turnover Ratio
 0.00 0.00 0.00 0.18 0.11
Cash Conversion Cycle
 0.00 0.00 -47.46 583.07 147.59
Days of Sales Outstanding
 0.00 0.00 0.00 674.44 171.80
Days of Inventory Outstanding
 0.00 0.00 0.00 -63.18 0.00
Days of Payables Outstanding
 0.00 0.00 47.46 28.18 24.21
Operating Cycle
 0.00 0.00 0.00 611.25 171.80
Cash Flow Ratios
Operating Cash Flow Per Share
 -24.93 -98.32 -197.91 -22.04K -455.06K
Free Cash Flow Per Share
 -24.94 -98.36 -210.40 -22.89K -459.07K
CapEx Per Share
 <0.01 0.04 12.49 849.04 4.00K
Free Cash Flow to Operating Cash Flow
 1.00 1.00 1.06 1.04 1.01
Dividend Paid and CapEx Coverage Ratio
 -2.73K -2.76K -15.84 -25.95 -113.68
Capital Expenditure Coverage Ratio
 -2.73K -2.76K -15.84 -25.95 -113.68
Operating Cash Flow Coverage Ratio
 -92.45 -88.59 -16.87 -14.71 -11.29
Operating Cash Flow to Sales Ratio
 0.00 0.00 0.00 -17.92 -10.08
Free Cash Flow Yield
-1148.03%-1167.68%-130.03%-4344.05%-704.70%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
 -0.10 -0.07 -1.75 -0.02 -0.13
Price-to-Sales (P/S) Ratio
 0.00 0.00 0.00 0.43 1.44
Price-to-Book (P/B) Ratio
 0.06 0.04 1.20 0.03 0.32
Price-to-Free Cash Flow (P/FCF) Ratio
 -0.09 -0.09 -0.77 -0.02 -0.14
Price-to-Operating Cash Flow Ratio
 -0.12 -0.09 -0.82 -0.02 -0.14
Price-to-Earnings Growth (PEG) Ratio
 >-0.01 <0.01 >-0.01 <0.01 >-0.01
Price-to-Fair Value
 0.06 0.04 1.20 0.03 0.32
Enterprise Value Multiple
 0.92 0.99 -1.00 0.75 0.15
Enterprise Value
 -7.97M -8.00M 9.08M -5.34M -1.20M
EV to EBITDA
 0.92 0.99 -1.00 0.75 0.15
EV to Sales
 0.00 0.00 0.00 -14.03 -1.72
EV to Free Cash Flow
 1.41 1.48 -0.70 0.75 0.17
EV to Operating Cash Flow
 1.42 1.48 -0.74 0.78 0.17
Tangible Book Value Per Share
 25.46 104.81 43.19 5.61K 203.77K
Shareholders’ Equity Per Share
 50.42 207.52 134.33 15.10K 204.16K
Tax and Other Ratios
Effective Tax Rate
 -0.03 0.02 0.04 0.05 0.10
Revenue Per Share
 0.00 0.00 0.00 1.23K 45.13K
Net Income Per Share
 -28.20 -113.82 -92.47 -22.85K -494.32K
Tax Burden
 0.98 0.98 0.96 0.95 0.90
Interest Burden
 0.74 0.77 0.65 1.01 1.01
Research & Development to Revenue
 0.00 0.00 0.00 10.67 7.31
SG&A to Revenue
 0.00 0.00 0.00 11.40 6.50
Stock-Based Compensation to Revenue
 0.00 0.00 0.00 0.07 0.18
Income Quality
 0.88 0.86 2.14 0.96 0.92
Currency in GBP